Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Inflammatory Bowel Diseases

Free Subscription 11.05.2025 3 Aliment Pharmacol Ther 1 Am J Gastroenterol 2 BMC Gastroenterol 1 Clin Gastroenterol Hepatol 1 Drugs 1 Gastroenterol Hepatol 2 Gastroenterology 5 Inflamm Bowel Dis 4 J Crohns Colitis 1 Lancet Gastroenterol Hepatol 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. SHINZAKI S, Takagi Y, Sato T
   Editorial: Real-World Effectiveness of Mirikizumab in Ulcerative Colitis-A Valuable but Preliminary Glimpse. Authors' Reply.
   Aliment Pharmacol Ther. 2025 May 5. doi: 10.1111/apt.70180.
   PubMed        
   
   
2. AINSWORTH MA, Frimor C
   Editorial: Real-World Effectiveness of Mirikizumab in Ulcerative Colitis-A Valuable but Preliminary Glimpse.
   Aliment Pharmacol Ther. 2025 May 5. doi: 10.1111/apt.70160.
   PubMed        
   
   
3. CASANOVA MJ, Rubin de Celix C, Riestra S, Lucendo AJ, et al
   Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of GETECCU.
   Aliment Pharmacol Ther. 2025 May 2. doi: 10.1111/apt.70172.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

4. ADLER J, Galanko JA, Ammoury R, Benkov KJ, et al
   HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.
   Am J Gastroenterol. 2025;120:1076-1086.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

5. PAN H, Zhai L, Cui M, Liu Y, et al
   Association between Dietary Inflammatory Index and Ulcerative Colitis: a case-control study.
   BMC Gastroenterol. 2025;25:343.
   PubMed         Abstract available
   
   
6. THESWET E, Brucker C, Kreienbuhl A, Greuter T, et al
   Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases.
   BMC Gastroenterol. 2025;25:336.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

7. VUYYURU SK, Shaban N, Yuan Y, Honap S, et al
   Medical Therapy for Acute Severe Ulcerative Colitis: A Systematic Review with Meta-analysis.
   Clin Gastroenterol Hepatol. 2025 May 6:S1542-3565(25)00329.
   PubMed         Abstract available
   
   

   
   Drugs

8. NARDONE OM, Vuyyuru SK, Yuan Y, Hanzel J, et al
   Differentiating IL-23 Inhibitors in Crohn's Disease.
   Drugs. 2025 May 5. doi: 10.1007/s40265-025-02183.
   PubMed         Abstract available
   
   

   
   Gastroenterol Hepatol

9. MINGUEZ A, Coello E, Garrido A, Ripoll P, et al
   Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and adjusted regimen in real world.
   Gastroenterol Hepatol. 2025;48:502253.
   PubMed         Abstract available
   
   

   
   Gastroenterology

10. ZHANG Y, Ran Q, Tang X, Wang Y, et al
    Creeping Fat and Muscle Hyperplasia in Crohn's Disease: A Critical Mechanistic Link for Stricture Formation.
    Gastroenterology. 2025 May 2:S0016-5085(25)00665.
    PubMed        
    
    
11. KELM M, Flemming S
    The importance of the mesentery in the pathophysiology of Crohn's disease.
    Gastroenterology. 2025 May 2:S0016-5085(25)00664.
    PubMed        
    
    

    
    Inflamm Bowel Dis

12. FENG Y, Wang S, Li S
    Non-Typhoidal Salmonella Infections and Inflammatory Bowel Disease Risk: New Findings and Multidimensional Perspectives for Future Research.
    Inflamm Bowel Dis. 2025 May 5:izaf082. doi: 10.1093.
    PubMed        
    
    
13. PAL P, Mateen MA, Gupta R, Tandan M, et al
    Multifaceted Endoscopic Approach (Stricturotomy, Balloon Dilation, Fistulotomy, and Seton Placement) Guided by Intestinal Ultrasound to Avert Surgery in Complicated Crohn's Disease During Lactation.
    Inflamm Bowel Dis. 2025 May 2:izaf076. doi: 10.1093.
    PubMed        
    
    
14. MCAULIFFE T, Salwen-Deremer JK, Siegel CA
    Disparities in Access and Treatment for Rural Patients With Inflammatory Bowel Disease: A Survey of Inflammatory Bowel Disease Patients and Providers.
    Inflamm Bowel Dis. 2025 May 8:izaf090. doi: 10.1093.
    PubMed         Abstract available
    
    
15. ALBERT S, Marques P, Algarra A, Blanc E, et al
    Monitoring Structural Bowel Damage in Patients With Crohn's Disease Using Intestinal Ultrasonography: Can It Be Reversed by Biological Treatment?
    Inflamm Bowel Dis. 2025 May 8:izaf100. doi: 10.1093.
    PubMed         Abstract available
    
    
16. LOVETT GC, Schulberg JD, Hamilton AL, Wright EK, et al
    Crohn's Disease Stricture Response to Treatment Assessed with Magnetic Resonance Imaging and Intestinal Ultrasound: STRIDENT Randomized Trial.
    Inflamm Bowel Dis. 2025 May 8:izaf073. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

17. TONTINI GE, Rath T
    Be precise, be reproducible! The emerging role of artificial intelligence in inflammatory bowel disease endoscopy.
    J Crohns Colitis. 2025;19:jjaf046.
    PubMed        
    
    
18. THOMAS DR, Huangfu G, Yeaman F, Sukudom S, et al
    Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals.
    J Crohns Colitis. 2025 May 7:jjaf078. doi: 10.1093.
    PubMed         Abstract available
    
    
19. GOODWIN SW, Haan M, Yuan Y, Wilk P, et al
    Spatial mapping and geographic variation of inflammatory bowel disease in Canada: A population-based study.
    J Crohns Colitis. 2025 May 6:jjaf079. doi: 10.1093.
    PubMed         Abstract available
    
    
20. MELON-ARDANAZ E, Veny M, Corraliza AM, Gudino V, et al
    Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patients.
    J Crohns Colitis. 2025 May 5:jjaf076. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

21. HANNA LN, Munster LJ, Joshi S, Wendelien van der Bilt JD, et al
    Isolated perianal Crohn's disease: a systematic review and expert consensus proposing novel diagnostic criteria and management advice.
    Lancet Gastroenterol Hepatol. 2025 Apr 29:S2468-1253(25)00007.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

22. SINGH AK, Ainciburu M, Wynne K, Bhat SA, et al
    De novo DUOX2 expression in neutrophil subsets shapes the pathogenesis of intestinal disease.
    Proc Natl Acad Sci U S A. 2025;122:e2421747122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.